JAMES MAY: Open Payments
NPI 1396727780 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 13 payments from 8 companies in 2025. Trend: 2023 $50 · 2024 $364 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $139 |
| Teva Pharmaceuticals USA, Inc. | 3 | $98 |
| Alkermes, Inc. | 3 | $54 |
| bioMerieux Inc | 1 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $15 |
Products named: CAPLYTA, AUSTEDO XR, ARISTADA, FilmArray Torch Module, REXULTI, TRINTELLIX, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
